A federal government grant-backed trial in Queensland will be testing an intravenous treatment monitoring system on hospitalised babies.
The monitoring system involves attaching a near-infrared sensor to a baby's skin near the IV site to monitor continuously the surrounding tissues. It sets off alarms when it detects a volume change in those tissues.
WHY IT MATTERS
In Australia, over 18,000...
